MMP2 and prostate carcinoma: A study by Xu et al. demonstrated that in human prostate cancer both MK2 and Hsp27 are important for TGFβ-mediated up-regulation of MMP-2 activity and cell invasion which was inhibited by SB203580, a p38MAPK inhibitor [50].